The reason I am posting this is the phenomenal increase in ACOR's price, from 2.25 to 8.5, based on unexpectedly good phase III results for its MS drug. Their drug increased the walking speed by ~25% in SOME people, and the price increased by approx factor of 4 in one day with a increase in volume from 42,000 shares to 24,000,000 shares.
This makes me realize (dah) that I need to pay more attention to biotech's that have drugs in Phase III testing. So I ran a list, and here they are. I am asking for discussion on these stocks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.